YATSEN HOLDING LTD-ADR (YSG)

US9851942089 - ADR

4.21  +0.06 (+1.45%)

After market: 4.21 0 (0%)

Fundamental Rating

5

YSG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. While YSG has a great health rating, there are worries on its profitability. YSG has a decent growth rate and is not valued too expensively.



2

1. Profitability

1.1 Basic Checks

YSG had negative earnings in the past year.
YSG had negative earnings in each of the past 5 years.
YSG had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

YSG's Return On Assets of -14.94% is on the low side compared to the rest of the industry. YSG is outperformed by 72.97% of its industry peers.
YSG has a Return On Equity (-18.08%) which is in line with its industry peers.
Industry RankSector Rank
ROA -14.94%
ROE -18.08%
ROIC N/A
ROA(3y)-16.68%
ROA(5y)-20.05%
ROE(3y)-20.86%
ROE(5y)-24.99%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

YSG has a better Gross Margin (73.60%) than 83.78% of its industry peers.
YSG's Gross Margin has improved in the last couple of years.
YSG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y3.01%

8

2. Health

2.1 Basic Checks

YSG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for YSG has been reduced compared to 1 year ago.
YSG has less shares outstanding than it did 5 years ago.
There is no outstanding debt for YSG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 1.06, we must say that YSG is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.06, YSG is doing worse than 62.16% of the companies in the same industry.
YSG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.06
ROIC/WACCN/A
WACC7.54%

2.3 Liquidity

A Current Ratio of 4.83 indicates that YSG has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.83, YSG belongs to the best of the industry, outperforming 89.19% of the companies in the same industry.
A Quick Ratio of 4.25 indicates that YSG has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.25, YSG belongs to the top of the industry, outperforming 89.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.83
Quick Ratio 4.25

5

3. Growth

3.1 Past

The earnings per share for YSG have decreased by -2.49% in the last year.
The Revenue has decreased by -7.86% in the past year.
Measured over the past years, YSG shows a very strong growth in Revenue. The Revenue has been growing by 39.98% on average per year.
EPS 1Y (TTM)-2.49%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-1516.67%
Revenue 1Y (TTM)-7.86%
Revenue growth 3Y-13.26%
Revenue growth 5Y39.98%
Revenue growth Q2Q6.68%

3.2 Future

Based on estimates for the next years, YSG will show a very strong growth in Earnings Per Share. The EPS will grow by 129.29% on average per year.
YSG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.68% yearly.
EPS Next Y391.43%
EPS Next 2Y129.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.84%
Revenue Next 2Y12.68%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

YSG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 8.88, the valuation of YSG can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of YSG indicates a rather cheap valuation: YSG is cheaper than 91.89% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of YSG to the average of the S&P500 Index (20.72), we can say YSG is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.88

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

YSG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as YSG's earnings are expected to grow with 129.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y129.29%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

YSG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

YATSEN HOLDING LTD-ADR

NYSE:YSG (5/2/2024, 6:30:26 PM)

After market: 4.21 0 (0%)

4.21

+0.06 (+1.45%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap453.44M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.88
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.94%
ROE -18.08%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 73.6%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.83
Quick Ratio 4.25
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-2.49%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y391.43%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-7.86%
Revenue growth 3Y-13.26%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y